Ashokkumar Jain

Summary

Affiliation: Temple University
Country: USA

Publications

  1. ncbi Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Transplantation 92:453-60. 2011
  2. ncbi One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA, USA
    Transplantation 91:1025-30. 2011
  3. ncbi Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases
    Ashokkumar B Jain
    Department of Surgery, Division of Abdominal Organ Transplant, Temple University Hospital, Philadelphia, PA 19140, USA
    Exp Clin Transplant 8:4-8. 2010
  4. ncbi Incidence of abdominal wall numbness post-liver transplantation and its complications
    Ashokkumar Jain
    Division of Abdominal Organ Transplant, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Liver Transpl 15:1488-92. 2009
  5. ncbi Recurrent nonhepatic and de novo malignancies after liver transplantation
    Ashokkumar Jain
    Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 88:706-10. 2009
  6. ncbi Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
    Ashokkumar Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 14:202-9. 2008
  7. ncbi Liver grafts from donors with central nervous system tumors: a single-center perspective
    Randeep Kashyap
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 15:1204-8. 2009
  8. ncbi Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients
    Ashokkumar Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Centre, Rochester, NY 14642, USA
    Transpl Int 19:27-37. 2006
  9. ncbi Outcomes of renal transplantation in older high risk recipients: is there an age effect?
    Andreas Karachristos
    Temple University School of Medicinem, Philadelphia, Pennsylvania 19140, USA
    J Surg Res 161:173-8. 2010
  10. ncbi Elevation of CA 125 and CA 19-9 in patients with end-stage liver disease
    Ashish Singhal
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Int J Biol Markers 27:e147-51. 2012

Collaborators

Detail Information

Publications13

  1. ncbi Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Transplantation 92:453-60. 2011
    ..Hepatitis C virus (HCV) recurrence is universal after liver transplantation (LT). Whether the progression of recurrent HCV is faster after live-donor LT (LDLT) compared with deceased-donor LT (DDLT) is debatable...
  2. ncbi One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA, USA
    Transplantation 91:1025-30. 2011
    ..Tacrolimus has proven to be a potent immunosuppressive agent in orthotopic liver transplantation (OLT). The aim of this study is to examine its long-term efficacy and safety...
  3. ncbi Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases
    Ashokkumar B Jain
    Department of Surgery, Division of Abdominal Organ Transplant, Temple University Hospital, Philadelphia, PA 19140, USA
    Exp Clin Transplant 8:4-8. 2010
    ..The purpose of this study was to observe the changes in the pulmonary functions of patients who underwent liver transplant for the treatment of A1A deficiency...
  4. ncbi Incidence of abdominal wall numbness post-liver transplantation and its complications
    Ashokkumar Jain
    Division of Abdominal Organ Transplant, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Liver Transpl 15:1488-92. 2009
    ..More then 24% of the patients used the area for subcutaneous injections of insulin and/or interferon...
  5. ncbi Recurrent nonhepatic and de novo malignancies after liver transplantation
    Ashokkumar Jain
    Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 88:706-10. 2009
    ..However, the data for patients with a prior history of nonhepatic malignancy and its recurrence post-LTx are limited...
  6. ncbi Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
    Ashokkumar Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 14:202-9. 2008
    ..All patients responded to steroid therapy. None of the patients required any antibody preparation. In conclusion, IV MMF with tacrolimus and steroids is useful and required antirejection therapy in 6.1% of liver transplant recipients...
  7. ncbi Liver grafts from donors with central nervous system tumors: a single-center perspective
    Randeep Kashyap
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 15:1204-8. 2009
    ....
  8. ncbi Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients
    Ashokkumar Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Centre, Rochester, NY 14642, USA
    Transpl Int 19:27-37. 2006
    ..3% of adults died and 69.4% grafts were lost. An overall incidence of 4.2% thrombotic and 3.2% nonthrombotic complications was observed. Rate of HAT was higher in children, but survival was better compared with adults...
  9. ncbi Outcomes of renal transplantation in older high risk recipients: is there an age effect?
    Andreas Karachristos
    Temple University School of Medicinem, Philadelphia, Pennsylvania 19140, USA
    J Surg Res 161:173-8. 2010
    ..The purpose of this study was to evaluate long-term outcomes in high risk renal transplant recipients over 60 years of age compared with those younger than 60 years of age...
  10. ncbi Elevation of CA 125 and CA 19-9 in patients with end-stage liver disease
    Ashish Singhal
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Int J Biol Markers 27:e147-51. 2012
    ..They are reported to be elevated in a variety of nonneoplastic clinical situations, including end-stage liver disease (ESLD). However, their prevalence and degree of elevation in patients with ESLD remained unclear...
  11. ncbi Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation
    Ashokkumar Jain
    Department of Surgery, Transplant Division, Strong Memorial Hospital, University of Rochester, Rochester, NY 14642, USA
    Transplantation 80:859-64. 2005
    ..5% improvement at 1 year. Three patients developed renal failure. Six patients died in the follow-up period. Addition of MMF with reduced tacrolimus dose resulted in sustained improvement in renal function in 58% of patients...
  12. ncbi Improving survival in decompensated cirrhosis
    Amar Nath Mukerji
    Liver Transplant Program, Department of Surgery, Temple University Hospital, 3401 N Broad Street, Suite C640 Parkinson Pavillion, Philadelphia, PA 19140, USA
    Int J Hepatol 2012:318627. 2012
    ..Sparing and judicious use of steroids needs to be borne in mind in treatment of ARDS and acute hepatitis from alcohol or autoimmune process...
  13. ncbi Oriental cholangiohepatitis masquerading as cholangiocarcinoma: A rare presentation that surgeons need to know
    Smit Singla
    Department of Surgery, Temple University Hospital, 3401 N Broad Street, Philadelphia, PA 19140, USA
    Int J Surg Case Rep 3:235-7. 2012
    ....